Ligand validation:7PD2

MET: METHIONINE

MET is a Ligand Of Interest in 7PD2 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7PD2_MET_B_403	29%	98%	0.217	0.878	0.25	0.04	-	-	0	0	100%	1
7PD2_MET_A_403	18%	97%	0.24	0.827	0.19	0.13	-	-	0	0	100%	1
7PD1_MET_B_403	96%	69%	0.079	0.987	0.77	0.42	-	-	0	0	100%	1
5HR6_MET_B_501	100%	56%	0.033	0.996	1.07	0.62	-	-	0	0	100%	1
3TQW_MET_A_238	100%	46%	0.039	0.992	0.87	1.2	1	1	1	0	100%	1
3AYL_MET_A_905	99%	42%	0.048	0.984	1.31	0.94	1	-	1	0	100%	1
3IIX_MET_A_1401	99%	51%	0.056	0.989	0.78	1.09	-	1	0	0	100%	1
5URB_MET_A_603	99%	43%	0.06	0.989	0.94	1.27	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.